Brain structures involved in the behavioral stimulant effect of central serotonin release

Brain Research

Volumn 772, Issue 1-2, 1997, Pages 121-134

  Vanderwolf, C H ^a   McLauchlin, M ^a   Dringenberg, Hans C ^a   Baker, G B ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

5,7 Dihydroxytryptamine; Amphetamine; Locomotion; Serotonin; Serotonin syndrome

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; AMPHETAMINE; FENCLONINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIENCEPHALON; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; TEGMENTUM; VOLUNTARY MOVEMENT;

ANIMALS; BRAIN; DRUG THERAPY, COMBINATION; EFFERENT PATHWAYS; MALE; METHYSERGIDE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; P-CHLOROAMPHETAMINE; RATS; SEROTONIN; SEROTONIN AGENTS; STIMULATION, CHEMICAL; TRANYLCYPROMINE; TRYPTOPHAN;

EID: 0030807694     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00870-6     Document Type: Article

References (91)

1. 1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis. Pharmacol. Toxicol. 72:1993;398-406.
2. Ahlman H., Grillner S., Udo M. The effect of 5-HTP on the static fusimotor activity and the tonic stretch reflex of an extensor muscle. Brain Res. 27:1971;393-396.
3. Andén N.E., Jukes M.G.M., Lundberg A. Spinal reflexes and monoamine liberation. Nature. 202:1964;1222-1223.
4. Anderson E.G. Bulbospinal serotonin-containing neurons and motor control. Fed. Proc. 31:1972;107-112.
5. Anderson E.G., Shibuya T. The effects of 5-hydroxytryptophan and L-tryptophan on spinal synaptic activity. J. Pharmacol. Exp. Ther. 153:1966;352-360.
6. Asin K.E., Fibiger H.C. An analysis of neuronal elements within the median nucleus of the raphe that mediate lesion-induced increases in locomotor activity. Brain Res. 268:1983;211-223.
7. Baker G.B., Coutts R.T., Rao T.S. Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br. J. Pharmacol. 92:1987;243-255.
8. Baldessarini R.J., Amatruda T.T. III, Griffith F.F., Gerson S. Differential effects of serotonin on turning and stereotypy induced by apomorphine. Brain Res. 93:1975;158-163.
9. Balfour D.J.K., Iyaniwura T.T. An investigation of amphetamine-induced release of 5-HT from rat hippocampal slices. Eur. J. Pharmacol. 109:1985;395-399.
10. Baumgarten H.G., Lachenmayer L. 5,7-Dihydroxytryptamine: improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z. Zellforsch. Mik. Anat. 135:1972;399-414.
11. Baumgarten H.G., Björklund A., Lachenmayer L., Nobin A. Evaluation of the effects of 5,7-dihydroxytryptamine on brain serotonin and catecholamine neurons in the rat CNS. Acta. Physiol. Scand. Suppl. 391:1973;1-22.
12. Baumgarten H.G., Klemm H.P., Lachenmayer L., Björklund A., Lovenberg W., Schlossberger H.G. Mode and mechanism of action of neurotoxic indoleamines: a review and a progress report. Ann. NY Acad. Sci. 305:1978;3-24.
13. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:1983;173-196.
14. Björklund A., Baumgarten H.G., Rensch A. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J. Neurochem. 24:1975;833-835.
15. Carter C.J., Pycock C.J. A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy. Naunyn-Schmiedebergs Arch. Pharmacol. 304:1978;135-139.
16. Carter C.J., Pycock C.J. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Life Sci. 23:1978;953-960.
17. Carter C.J., Pycock C.J. The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy. Naunyn-Schmiedebergs Arch. Pharmacol. 308:1979;51-54.
18. Carter C.J., Pycock C.J. The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour. Neuropharmacology. 20:1981;261-265.
19. 1B receptor. Br. J. Pharmacol. 110:1993;1621-1629.
20. Costall B., Naylor R.J. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei. Eur. J. Pharmacol. 29:1974;206-222.
21. Deakin J.F.W., Green A.R. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-dopa to rats. Br. J. Pharmacol. 64:1978;201-209.
22. De Simoni M.G., Giglio R., Dal Toso G., Kostowski W., Algeri S. Interaction between serotonergic and dopaminergic systems detected in striatum by differential pulse voltammetry. Eur. J. Pharmacol. 110:1985;289-290.
23. Dringenberg H.C., Hargreaves E.L., Baker G.B., Cooley R.K., Vanderwolf C.H. p-Chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav. Brain Res. 68:1995;229-237.
24. Dringenberg H.C., Vanderwolf C.H. 5-Hydroxytryptamine (5-HT) agonists: effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade. Brain Res. 728:1996;181-187.
25. Ellard C.G., Stewart D.J., Donaghy S., Vanderwolf C.H. Behavioural effects of neocortical and cingulate lesions in the Mongolian gerbil. Behav. Brain Res. 36:1990;41-51.
26. Elliott P., Wallis D.I. Serotonin and L-norepinephrine as mediators of altered excitability in neonatal rat motoneurones studied in vitro. Neuroscience. 47:1992;533-544.
27. 1A receptor agonists on locomotor activity in the guinea-pig. Br. J. Pharmacol. 112:1994;861-866.
28. Fuller R.W., Hines C.W., Mills J. Lowering of brain serotonin level by chloroamphetamines. Biochem. Pharmacol. 14:1965;483-488.
29. Gage F.H., Björklund A., Stenevi U., Dunnett S.B. Functional correlates of compensatory collateral sprouting by aminergic and cholinergic afferents in the hippocampal formation. Brain Res. 268:1983;39-47.
30. Gerson S.C., Baldessarini R.J. Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine. Brain Res. 85:1975;140-145.
31. 2 receptors. Br. J. Pharmacol. 84:1985;743-753.
32. Grabowska M. Influence of apomorphine on brain serotonin turnover rate. Pharmacol. Biochem. Behav. 3:1975;589-591.
33. Grahame-Smith D.G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18:1971;1053-1066.
34. Green A.R., Grahame-Smith D.G. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology. 13:1974;949-959.
35. Green A.R., Kelly P.H. Evidence concerning the involvement of 5-hydroxytryptamine in locomotor activity produced by amphetamine or tranylcypromine plus L-dopa. Br. J. Pharmacol. 57:1976;141-147.
36. S. Grillner, Control of locomotion in bipeds, tetrapods, and fish, in: J.M. Brookhart, V.B. Mountcastle, V.B. Brooks, S.R. Geiger (Eds.), Handbook of Physiology, Section I: Neurophysiology, Vol. II, Motor Control, Part 2, American Physiological Society, Bethesda, MD, 1981, pp. 1179-1236.
37. S.P. Grossman, A. Sclafani, Sympathomimetic amines, in: E. Furchtgott (Ed.), Pharmacological and Biophysical Agents and Behavior, Academic Press, New York, 1971, pp. 269-344.
38. Hillegaart V. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat. Physiol. Behav. 48:1990;143-148.
39. Hinsey J.C., Ranson S.W., McNattin R.F. The role of the hypothalamus and mesencephalon in locomotion. Arch. Neurol. Psychiatry. 23:1930;1-43.
40. Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikström H., Arvidsson L.-E., Hacksell U., Nilsson J.L.G. 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J. Neural Transm. 55:1982;169-188.
41. Jacobs B.L. An animal behavior model for studying central serotonergic synapses. Life Sci. 19:1976;777-786.
42. Jacobs B.L., Klemfuss H. Brain stem and spinal cord mediation of a serotonergic behavioral syndrome. Brain Res. 100:1975;450-457.
43. Johnson M.P., Huang X., Oberlender R., Nash J.F., Nicols D.E. Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine. Eur. J. Pharmacol. 191:1990;1-10.
44. Koe K.B., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154:1966;499-516.
45. Laughton N.B. Studies on the nervous regulation of progression in mammals. Am. J. Physiol. 70:1924;358-384.
46. Lidov H.G.W., Molliver M.E. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res. Bull. 8:1982;389-430.
47. Lipska B.K., Jaskiw G.E., Arya A., Weinberger D.R. Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacol. Biochem. Behav. 43:1992;1247-1252.
48. Magoun H.W. Caudal and cephalic influences of the brain stem reticular formation. Physiol. Rev. 30:1950;459-474.
49. J. Maj, The influence of dopaminergic agents on serotonin neurons, in: G. Sedvall, B. Uvnas, Y. Zotterman (Eds.), Antipsychotic Drugs, Pharmacodynamics and Pharmacokinetics, Pergamon, Oxford, 1976, pp. 235-241.
50. McCall R.B., Aghajanian G.K. Denervation supersensitivity to serotonin in the facial nucleus. Neuroscience. 4:1979;1501-1510.
51. Nelson D.L., Herbet A., Bourgoin S., Glowinski J., Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol. Pharmacol. 14:1979;983-995.
52. 3H]dopamine by L-5-hydroxytryptophan. Brain Res. 45:1972;499-505.
53. Nicolaou N.M., Garcia-Munoz M., Arbuthnott G.W., Eccleston D. Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei. Eur. J. Pharmacol. 57:1979;295-305.
54. M.J. Norušis, Advanced Statistics SPSS/PC+ for the IBM PC/XT/AT, SPSS, Chicago, IL, 1986.
55. Oliveras J.L., Bourgoin S., Hery F., Besson J.M., Hamon M. The topographical distribution of serotonergic terminals in the spinal cord of the cat: biochemical mapping by the combined use of microdissection and microassay procedures. Brain Res. 138:1977;393-406.
56. 3H]5-hydroxytryptamine. Neuroscience. 6:1981;115-138.
57. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
58. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Sydney, 1986.
59. Peck B.K., Vanderwolf C.H. Effects of raphe stimulation on hippocampal and neocortical activity and behaviour. Brain Res. 568:1991;244-252.
60. Rebec G.V., Alloway K.D., Curtis S.D. Apparent serotonergic modulation of the dose-dependent biphasic response of neostriatal neurons produced by D-amphetamine. Brain Res. 210:1981;277-289.
61. Robertson B., Baker G.B., Vanderwolf C.H. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior. Brain Res. 555:1991;265-275.
62. Ross S.B., Ögren S.O., Renyi A.L. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain Acta Pharmacol. Toxicol. 41:1977;337-352.
63. Rudnick G., Wall S.C. p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry. 31:1992;6710-6718.
64. Schiørring E. Amphetamine induced selective stimulation of certain behavior items with concurrent inhibition of others in an open field test with rats. Behaviour. 39:1971;1-17.
65. Segal D.S. Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy. Brain Res. 116:1976;267-276.
66. Sharp T., Zetterstrom T., Christmanson L., Ungerstedt U. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci. Lett. 72:1986;320-324.
67. Sheard M.H., Aghajanian G.K. Stimulation of the midbrain raphe: effect on serotonin metabolism. J. Pharmacol. Exp. Ther. 163:1968;425-430.
68. S. Siegel, Non-parametric Statistics for the Behavioral Sciences, McGraw Hill, New York, 1956.
69. Silverman A.P. The social behavior of laboratory rats and the action of chlorpromazine and other drugs. Behaviour. 27:1966;1-38.
70. Sloviter R.S., Drust E.G., Connor J.D. Evidence that serotonin mediates some behavioral effects of amphetamine. J. Pharmacol. Exp. Ther. 206:1978;348-352.
71. H.W.M. Steinbusch, R. Nieuwenhuys, The raphe nuclei of the rat brainstem: a cytoarchitectonic and immunohistochemical study, in: P.C. Emson (Ed.), Chemical Neuroanatomy, Raven Press, New York, 1983, pp. 131-207.
72. 1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur. J. Pharmacol. 106:1985;271-282.
73. Trulson M.E., Eubanks E.E., Jacobs B.E. Behavioral evidence of supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J. Pharmacol. Exp. Ther. 198:1976;23-32.
74. Vanderwolf C.H. Cerebral activity and behavior: control by central cholinergic and serotonergic systems. Int. Rev. Neurobiol. 30:1988;225-340.
75. Vanderwolf C.H. A general role for serotonin in the control of behavior studies with intracerebral 5,7-dihydroxytryptamine. Brain Res. 504:1989;192-198.
76. Vanderwolf C.H., Baker G.B. The role of brain noradrenaline in cortical activation and behavior: a study of lesions of the locus coeruleus, medial thalamus and hippocampus-neocortex and of muscarinic blockade in the rat. Behav. Brain Res. 78:1996;225-234.
77. Vanderwolf C.H., Baker G.B., Dickson C. Serotonergic control of cerebral activity and behavior: models of dementia. Ann. NY Acad. Sci. 600:1990;366-383.
78. Vanderwolf C.H., Cooley R.K. Phenoxybenzamine reduces mortality associated with intracerebral injections of excitatory neurotoxins. Pharmacol. Biochem. Behav. 38:1991;689-690.
79. Vanderwolf C.H., Kelly M.E., Kraemer P., Streather A. Are emotion and motivation localized in the limbic system and nucleus accumbens? Behav. Brain Res. 27:1988;45-58.
80. Vanderwolf C.H., Kolb B., Cooley R.K. Behavior of the rat after removal of the neocortex and hippocampal formation. J. Comp. Physiol. Psychol. 92:1978;156-175.
81. Vanderwolf C.H., Leung L.-W.S., Baker G.B., Stewart D.J. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine. Brain Res. 504:1989;181-191.
82. C.H. Vanderwolf, D. Penava, Potentiation of the effects of antimuscarinic drugs on behavior by serotonin depletion: specificity and relation to learning and memory, in: E.D. Levin, M.W. Decker, L.L. Butcher (Eds.), Neurotransmitter Interactions and Cognitive Function, Birkhauser, Boston, MA, 1992, pp. 257-276.
83. Vanderwolf C.H., Stewart D.J. Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine, and amphetamine. Physiol. Behav. 38:1986;57-65.
84. Waldmeier P.C. Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor. Eur. J. Pharmacol. 60:1979;315-322.
85. Waldmeier P.C., Delini-Stula A.A. Serotonin-dopamine interactions in the nigrostriatal system. Eur. J. Pharmacol. 55:1979;363-373.
86. Wallis D.I., Wu J. Fast and slow ipsilateral and contralateral spinal reflexes in the neonate rat are modulated by 5-HT. Gen. Pharmacol. 23:1992;1035-1044.
87. Watson N.V., Hargreaves E.L., Penava D., Eckel L.A., Vanderwolf C.H. Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists. Brain Res. 597:1992;16-23.
88. Whishaw I.Q., Robinson T.E., Schallert T., De Ryck M., Ramirez V.D. Electrical activity of the hippocampus and neocortex in rats depleted of brain dopamine and norepinephrine: relations to behavior and effects of atropine. Exp. Neurol. 62:1978;748-767.
89. White S.R., Fung S.J. Serotonin depolarizes cat spinal motoneurones in situ and decreases motoneuron afterhyperpolarizing potentials. Brain Res. 502:1989;205-213.
90. B receptors in the median raphe nucleus. Behav. Brain Res. 59:1993;83-93.
91. Yoshimoto K., McBride W.J. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17:1992;401-407.